SARS-CoV-2 B.1.1.420 and B.1.617.1 immune escape variants reported in France

Since its emergence in Wuhan, China, in December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19 (coronavirus disease 2019), is rapidly spreading, with numerous variants being observed around the world. A high transmission rate would indicate an undergoing process of positive selection of variants, which might allow the virus to acquire some advantageous genetic traits. […]

Continue reading »

Experts call for better design of early drug trials for Alzheimer’s and related dementias

An expert panel convened by the Alzheimer’s Drug Discovery Foundation (ADDF) and The Association for Frontotemporal Degeneration (AFTD) provides guidance on best practices for the design of early drug trials for Alzheimer’s disease, frontotemporal degeneration (FTD), and other neurodegenerative dementias. Their guidance was published in the May 18, 2021 issue of Neurology, the medical journal of the American Academy of […]

Continue reading »
1 852 853 854 855 856 1,322